Related Experiment Videos
Malignant peripheral nerve sheath tumour in the maxilla associated with von Recklinghausen's disease
Y Muraki1, A Tateishi, K Tominaga
1First Department of Oral and Maxillofacial Surgery, Kyushu Dental College, 2-6-1 Manazuru, Kokurakita-ku, Kitakyushu 803.
Abstract:
Malignant transformation of neurofibromatosis is one of the most serious complications of von Recklinghausen's disease (VRD). The most common associated malignancy is the malignant peripheral nerve sheath tumour (MPNST). Few cases of MPNST associated with VRD in the maxillary region have been reported. This report describes a rare case of MPNST in the maxilla and the aggressive nature of MPNST associated with VRD.
Insights
Malignant peripheral nerve sheath tumors (MPNST) are a severe complication of von Recklinghausen's disease (VRD). This case highlights an aggressive MPNST in the maxilla, a rare but serious manifestation of VRD.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- Neurofibromatosis, also known as von Recklinghausen's disease (VRD), is a genetic disorder.
- Malignant transformation is a serious complication of VRD, with malignant peripheral nerve sheath tumors (MPNST) being the most common associated malignancy.
- MPNST in the maxillary region are exceptionally rare.
Observation:
- This report details a rare case of MPNST occurring in the maxilla.
- The tumor exhibited aggressive characteristics.
- The patient had a pre-existing diagnosis of VRD.
Findings:
- The study confirms the occurrence of MPNST in the maxillary region in a patient with VRD.
- The observed MPNST demonstrated aggressive behavior, consistent with the known aggressive nature of these tumors in the context of VRD.
- This case adds to the limited literature on maxillary MPNST associated with VRD.
Implications:
- Early diagnosis and aggressive management are crucial for MPNST associated with VRD.
- Further research is needed to understand the specific mechanisms driving MPNST development in the maxilla in VRD patients.
- This case underscores the importance of vigilance for rare but aggressive malignancies in patients with neurofibromatosis.